.jpg?#)
Biocon Q2 Results: Company Swings Into Profit, Revenue Rises
The company has also announced that it has approved the issue of commercial papers of up to Rs 550 crore on a private placement basis.
The company has also announced that it has approved the issue of commercial papers of up to Rs 550 crore on a private placement basis.
What's Your Reaction?
